All In MedTech

Device Trial Radar · NCT00619762

Immediate Postmastectomy Breast Reconstruction (Strattice Breast)

A Multicenter, Prospective, Open-Label Study to Assess the Clinical Outcomes of LTM Use in Two-Stage Breast Reconstruction Immediately Post Mastectomy

Last checked: Nov 19, 2026Latest source record: Nov 8, 2016 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

17

Actual

Start

Oct 2007

Primary completion

Oct 2009

Study completion Dec 2009

Sponsor

Lead sponsor
LifeCellNot on our public-company list
Sponsor type
Industry
First posted
Feb 21, 2008

More device trials from this sponsor

Design

Study type
Observational
Who can join
Female only, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This prospective, multicenter, open-label study will assess the clinical outcomes of the LTM product in three planned analyses. The primary objective of this study is to prospectively assess the clinical outcomes associated with the use of LTM in two-stage (expander then permanent implant) immediate post-mastectomy breast reconstruction.

Conditions

  • Breast Cancer

Interventions

  • LTM - a porcine-based surgical meshDevice

    Use of LTM to support weak and/or absent soft tissue to facilitate immediate breast reconstruction postmastectomy

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Histology Sample Evaluations Assessing Incorporation of StratticeTM Reconstructive Tissue MatrixTime frame: At the time of expander/implant exchange (Stage II),

Locations

5 sites in 1 country. Site status is shown where the registry gives one.

  • Site not named

    Washington D.C., District of Columbia

  • Site not named

    Chicago, Illinois

  • Site not named

    Great Neck, New York

2 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.